DAVID CHORLEY: Open Payments
NPI 1154386928 · BIXBY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 47 payments from 17 companies in 2025. Trend: 2023 $444 · 2024 $685 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $189 |
| ABBVIE INC. | 16 | $168 |
| Vanda Pharmaceuticals Inc. | 3 | $71 |
| Corium, LLC | 2 | $67 |
| Almatica Pharma LLC | 3 | $57 |
| Madrigal Pharmaceuticals | 2 | $55 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Intra-Sana Laboratories | 3 | $46 |
| Alkermes, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
Products named: SPRAVATO, VRAYLAR, FANAPT, Azstarys, LOREEV XR, REZDIFFRA, COBENFY, QULIPTA.
Industry payments across OK — which companies pay providers there.
